Compare LTRN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTRN | MDCX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 10.9M |
| IPO Year | 2020 | 2025 |
| Metric | LTRN | MDCX |
|---|---|---|
| Price | $0.46 | $1.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $17.50 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 218.7K | 53.9K |
| Earning Date | 11-27-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.65 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $1.63 |
| 52 Week High | $4.34 | $115.50 |
| Indicator | LTRN | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 26.16 | 25.31 |
| Support Level | N/A | N/A |
| Resistance Level | $0.84 | $2.16 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 2.47 | 9.92 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.